Keyphrases
Preeclampsia
100%
Placebo-controlled Study
100%
Sildenafil
100%
Phosphodiesterase Type V Inhibitors
100%
Placebo
33%
Day Range
33%
Drug Concentration
16%
Pharmacokinetics
16%
Clinical Trials
16%
Adverse Events
16%
Treatment Group
16%
Placebo Groups
16%
Median Time
16%
During Pregnancy
16%
Plasma Samples
16%
Gestational Age
16%
Maternal Infection
16%
Intention-to-treat Analysis
16%
Data Analyzing
16%
Sildenafil Citrate
16%
Maternal Morbidity
16%
Modified Intention-to-treat
16%
Pregnancy Duration
16%
Escalating Dose
16%
Fetal Morbidity
16%
Prolonged Pregnancy
16%
Dosing Regimen
16%
Fetal Mortality
16%
Infant Weight
16%
Cord Blood pH
16%
Medicine and Dentistry
Placebo-Controlled Study
100%
Pre-Eclampsia
100%
Sildenafil
100%
Phosphodiesterase V Inhibitor
100%
Placebo
42%
Clinical Trial
14%
Pharmacokinetics
14%
Intention-to-Treat Analysis
14%
Drug Therapy
14%
Adverse Event
14%
Maternal Disease
14%
Drug Dose Regimen
14%
Gestation Period
14%
Gestational Age
14%
Neutron Capture Therapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Preeclampsia
100%
Placebo-Controlled Study
100%
Phosphodiesterase V Inhibitor
100%
Sildenafil
100%
Placebo
42%
Drug Concentration
14%
Clinical Trial
14%
Adverse Event
14%
Maternal Disease
14%
Pharmacokinetics
14%